173 related articles for article (PubMed ID: 33063436)
1. Targeting the epigenetic addiction of Merkel cell carcinoma.
Mauri F; Blanpain C
EMBO Mol Med; 2020 Nov; 12(11):e13347. PubMed ID: 33063436
[TBL] [Abstract][Full Text] [Related]
2. LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma.
Leiendecker L; Jung PS; Krecioch I; Neumann T; Schleiffer A; Mechtler K; Wiesner T; Obenauf AC
EMBO Mol Med; 2020 Nov; 12(11):e12525. PubMed ID: 33026191
[TBL] [Abstract][Full Text] [Related]
3. Decreased H3K27me3 Expression Is Associated With Merkel Cell Polyomavirus-negative Merkel Cell Carcinoma, Especially Combined With Cutaneous Squamous Cell Carcinoma.
Matsushita M; Iwasaki T; Wardhani LO; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Anticancer Res; 2019 Oct; 39(10):5573-5579. PubMed ID: 31570452
[TBL] [Abstract][Full Text] [Related]
4. Classical and Variant Merkel Cell Carcinoma Cell Lines Display Different Degrees of Neuroendocrine Differentiation and Epithelial-Mesenchymal Transition.
Gravemeyer J; Lange A; Ritter C; Spassova I; Song L; Picard D; Remke M; Horny K; Sriram A; Gambichler T; Schadendorf D; Hoffmann D; Becker JC
J Invest Dermatol; 2021 Jul; 141(7):1675-1686.e4. PubMed ID: 33600825
[TBL] [Abstract][Full Text] [Related]
5. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
[TBL] [Abstract][Full Text] [Related]
6. Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities.
Das BK; Kannan A; Velasco GJ; Kunika MD; Lambrecht N; Nguyen Q; Zhao H; Wu J; Gao L
Cell Rep Med; 2023 Jul; 4(7):101101. PubMed ID: 37421947
[TBL] [Abstract][Full Text] [Related]
7. Current and preclinical treatment options for Merkel cell carcinoma.
Celikdemir B; Houben R; Kervarrec T; Samimi M; Schrama D
Expert Opin Biol Ther; 2023; 23(10):1015-1034. PubMed ID: 37691397
[TBL] [Abstract][Full Text] [Related]
8. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Morimoto Y; Fushimi A; Yamashita N; Hagiwara M; Bhattacharya A; Cheng J; Frost TC; Ahmad R; Daimon T; Huang L; Hata T; Takahashi H; Yamamoto M; Suzuki Y; DeCaprio JA; Kufe D
Oncogene; 2022 Jul; 41(27):3511-3523. PubMed ID: 35688945
[TBL] [Abstract][Full Text] [Related]
9. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.
Sengupta D; Kannan A; Kern M; Moreno MA; Vural E; Stack B; Suen JY; Tackett AJ; Gao L
Epigenetics; 2015; 10(6):460-6. PubMed ID: 25941994
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma - recent advances in the biology, diagnostics and treatment.
Czapiewski P; Biernat W
Int J Biochem Cell Biol; 2014 Aug; 53():536-46. PubMed ID: 24811434
[TBL] [Abstract][Full Text] [Related]
11. Delta-Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma.
Xie H; Kaye FJ; Isse K; Sun Y; Ramoth J; French DM; Flotte TJ; Luo Y; Saunders LR; Mansfield AS
Oncologist; 2020 Sep; 25(9):810-817. PubMed ID: 32372416
[TBL] [Abstract][Full Text] [Related]
12. Merkel Cell Polyomavirus‒Negative Merkel Cell Carcinoma Originating from In Situ Squamous Cell Carcinoma: A Keratinocytic Tumor with Neuroendocrine Differentiation.
Kervarrec T; Appenzeller S; Samimi M; Sarma B; Sarosi EM; Berthon P; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Benethon N; Bens G; Nardin C; Aubin F; Dinulescu M; Jullie ML; Pekár-Lukacs Á; Calonje E; Thanguturi S; Tallet A; Wobser M; Touzé A; Guyétant S; Houben R; Schrama D
J Invest Dermatol; 2022 Mar; 142(3 Pt A):516-527. PubMed ID: 34480892
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathogenesis of Merkel Cell Carcinoma.
DeCaprio JA
Annu Rev Pathol; 2021 Jan; 16():69-91. PubMed ID: 33228463
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Merkel cell carcinoma: a turning point in patient care.
Chan IS; Bhatia S; Kaufman HL; Lipson EJ
J Immunother Cancer; 2018 Mar; 6(1):23. PubMed ID: 29566749
[TBL] [Abstract][Full Text] [Related]
15. B-cell lymphoma-extra large is a promising drug target in Merkel cell carcinoma.
Fan K; Srinivas N; Kubat L; Gravemeyer J; Sucker A; Schadendorf D; Gambichler T; Becker JC
Br J Dermatol; 2023 Jul; 189(1):103-113. PubMed ID: 36991156
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Merkel Cell Carcinoma.
Nagase K; Narisawa Y
Curr Treat Options Oncol; 2018 Sep; 19(11):57. PubMed ID: 30238195
[TBL] [Abstract][Full Text] [Related]
18. The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells.
Song L; Bretz AC; Gravemeyer J; Spassova I; Muminova S; Gambichler T; Sriram A; Ferrone S; Becker JC
J Invest Dermatol; 2021 Apr; 141(4):903-912.e4. PubMed ID: 33002502
[TBL] [Abstract][Full Text] [Related]
19. Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma.
Ritter C; Fan K; Paulson KG; Nghiem P; Schrama D; Becker JC
Sci Rep; 2016 Feb; 6():21678. PubMed ID: 26902929
[TBL] [Abstract][Full Text] [Related]
20. Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma.
Harms PW; Verhaegen ME; Vo JN; Tien JC; Pratt D; Su F; Dhanasekaran SM; Cao X; Mangelberger D; VanGoor J; Choi JE; Ma VT; Dlugosz AA; Chinnaiyan AM
J Invest Dermatol; 2022 Mar; 142(3 Pt A):641-652. PubMed ID: 34474081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
